Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Dose-Response Relationship”

230 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 230 results

Early research (Phase 1)Study completedNCT00029900
What this trial is testing

ADI-PEG in Patients With Metastatic Melanoma

Who this might be right for
MelanomaNeoplasm Metastasis
FDA Office of Orphan Products Development 15
Not applicableStudy completedNCT05012709
What this trial is testing

Dose-response Relationship and the Evidence Based Multisensory Stimulation Intervention

Who this might be right for
Psychotic DisordersAnxietyComplementary Therapies+1 more
Jianan Psychiatric Center, Ministry of Health and Welfare 95
Testing effectiveness (Phase 2)Study completedNCT01728922
What this trial is testing

Dose-related Effects of Vitamin D3 on Immune Responses in Patients With Clinically Isolated Syndrome

Who this might be right for
Clinically Isolated SyndromeMultiple Sclerosis
University College Dublin 64
Not applicableActive Not RecruitingNCT06431230
What this trial is testing

School-based HIIT and Dose-Response Effects

Who this might be right for
AdolescentsPhysical ActivityAdipose Tissue+2 more
Wroclaw University of Health and Sport Sciences 600
Post-approval studies (Phase 4)Study completedNCT03138577
What this trial is testing

Dose-Response Relationships for Hemidiaphragmatic Paresis Following Ultrasound-Guided Supraclavicular Block

Who this might be right for
Surgery of Right Upper Extremity
Weill Medical College of Cornell University 24
Large-scale testing (Phase 3)Looking for participantsNCT07015892
What this trial is testing

Dose-Escalation Radiotherapy in Limited-Stage Small Cell Lung Cancer: A Phase III Randomized Trial

Who this might be right for
Small Cell Lung Carcinoma
Instituto de Investigación Biomédica de Salamanca 300
Testing effectiveness (Phase 2)Study completedNCT00460239
What this trial is testing

Buprenorphine's Dose Response Curve

Who this might be right for
Opioid-related Disorders
Johns Hopkins University 12
Early research (Phase 1)Study completedNCT00000899
What this trial is testing

A Study on the Effect of Chemotherapy Combined With Anti-HIV Drugs in HIV-Positive Patients

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 10
Testing effectiveness (Phase 2)Study completedNCT00134693
What this trial is testing

A Single Dose Of Compound SB-681323 Compared To Prednisolone On A Protein That Is an Indicator For Rheumatoid Arthritis

Who this might be right for
Arthritis, Rheumatoid
GlaxoSmithKline 77
Very early researchStudy completedNCT01129115
What this trial is testing

Dose Response Study of Aerobic Exercise in Older Adults

Who this might be right for
Alzheimer's Disease
Jeff Burns, MD 101
Testing effectiveness (Phase 2)Study completedNCT01977482
What this trial is testing

Evaluation of Dose Response Relationship, Safety and Efficacy of GSK1278863 in Hemodialysis-dependent Subjects With Chronic Kidney Disease Associated Anemia

Who this might be right for
Anaemia
GlaxoSmithKline 216
Early research (Phase 1)Study completedNCT02677844
What this trial is testing

Abemaciclib in Healthy Participants

Who this might be right for
Healthy
Eli Lilly and Company 35
Testing effectiveness (Phase 2)Study completedNCT05536752
What this trial is testing

QA102 Phase II Study in Subjects With Dry AMD

Who this might be right for
Dry Age-related Macular Degeneration
Smilebiotek Zhuhai Limited 150
Early research (Phase 1)Study completedNCT02752919
What this trial is testing

Study of Galunisertib in Healthy Participants

Who this might be right for
Healthy
Eli Lilly and Company 40
Early research (Phase 1)Study completedNCT00000710
What this trial is testing

A Phase I Safety, Efficacy, and Pharmacokinetic Study of 2',3'-Dideoxyinosine (ddI) Administered Twice Daily to Patients With AIDS or AIDS Related Complex

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 42
Large-scale testing (Phase 3)Study completedNCT00002124
What this trial is testing

A Double-Blind, Randomized, Dose Response Study of Three Doses of Delavirdine Mesylate (U-90152S) in Combination With Zidovudine (ZDV) Versus ZDV Alone in HIV-1 Infected Individuals With CD4 Counts of 200-500mm3

Who this might be right for
HIV Infections
Pharmacia and Upjohn 1,250
Post-approval studies (Phase 4)Study completedNCT00271479
What this trial is testing

Fractional Dose Tetravalent A, C, Y, W135 Meningococcal Polysaccharide Vaccine

Who this might be right for
Infections, MeningococcalMeningitis, Meningococcic
Epicentre 720
Not applicableLooking for participantsNCT07183579
What this trial is testing

Effective Dosing of Burosumab in XLH

Who this might be right for
X-linked Hypophosphatemia (XLH)
University of Nottingham 120
Testing effectiveness (Phase 2)Ended earlyNCT00090194
What this trial is testing

Improving Transplant Options of Highly Sensitized Recipients Using IGIV-C, 10%

Who this might be right for
Kidney Failure, Chronic
National Institute of Allergy and Infectious Diseases (NIAID) 56
Not applicableEnded earlyNCT03320564
What this trial is testing

Infiltration Effect on SUV

Who this might be right for
Dose Response Relationship, Drug
Wake Forest University Health Sciences 2
Load More Results